Parabacteroides goldsteinii

Last updated

Parabacteroides goldsteinii
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Kingdom: Pseudomonadati
Phylum: Bacteroidota
Class: Bacteroidia
Order: Bacteroidales
Family: Tannerellaceae
Genus: Parabacteroides
Species:
P. goldsteinii
Binomial name
Parabacteroides goldsteinii
(Song et al. 2006) Sakamoto and Benno 2006 [1]

Parabacteroides goldsteinii is a Gram-negative, obligately anaerobic bacterium belonging to the genus Parabacteroides within the phylum Bacteroidota and family Tannerellaceae. It is a commensal microorganism naturally present in the human gut microbiota and has attracted increasing scientific interests due to its potential roles in metabolic regulation, immune modulation, and host–microbe interactions. [2] [3] [4] [5] [6] [7] [8] [9] [10]

Contents

Morphology and Characteristics

P. goldsteinii is a non-spore-forming, non-motile, rod-shaped bacterium. Like other members of the genus, it is strictly anaerobic and thrives in low-oxygen environments such as the gastrointestinal tract [11] . The bacterium exhibits typical characteristics of Gram-negative cell wall architecture, including an outer membrane containing lipopolysaccharide [12] .

Ecology and Natural Habitat

P. goldsteinii is primarily found in the human gastrointestinal tract, where it exists as part of the normal gut microbiome in healthy individuals. Its abundance may vary depending on factors such as diet, age, metabolic status, and overall gut microbial composition [9] .

Biological and Functional Research

Research on P. goldsteinii has increased over the past decade, primarily through animal models, in vitro experiments, and strain-specific investigations. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]

A landmark study demonstrated that P. goldsteinii played a key role in the anti-obesity effects of polysaccharides derived from Hirsutella sinensis in a high-fat diet mouse model. Oral administration of P. goldsteinii was associated with reduced body weight gain, improved insulin sensitivity, enhanced intestinal barrier integrity, and increased expression of thermogenesis-related markers in adipose tissue. These effects were shown to be microbiota-dependent and strain-specific. [2]

Subsequent research further highlighted the involvement of P. goldsteinii in diet–microbiota–host metabolic interactions. In a study investigating the effects of dietary amino acid modulation, a lysine-restricted diet was shown to ameliorate obesity and metabolic dysfunction in high-fat diet–fed mice through selective enrichment of P. goldsteinii. Metabolomic analyses identified 1,4-methylimidazoleacetic acid (MIAA) as a key microbial metabolite associated with these effects. Increased levels of MIAA correlated with reduced adiposity, improved glucose homeostasis, enhanced intestinal barrier function, and attenuation of low-grade inflammation. Mechanistically, the study suggested that MIAA acts as a signaling molecule mediating host–microbe crosstalk, contributing to improved energy metabolism and metabolic flexibility. Importantly, fecal microbiota transplantation (FMT) experiments demonstrated that the metabolic benefits of lysine restriction were transferable and microbiota-dependent, supporting a causal role for P. goldsteinii and its associated metabolites in obesity regulation. [3]

2. Inflammation and Intestinal Barrier Function

Experimental studies have investigated P. goldsteinii in models of intestinal inflammation. In a mouse colitis model, enrichment and administration of an antibiotic-resistant P. goldsteinii strain was associated with attenuation of colitis severity. Mechanistic analyses suggested involvement of valine–isobutyrate metabolism and downstream activation of PPARγ-related pathways contributing to enhanced epithelial barrier function. [4]

Additional studies using animal models, including piglets, have reported reductions in inflammatory markers and improvements in gut barrier-related parameters following P. goldsteinii supplementation. [5]

Beyond inflammatory bowel disease models, P. goldsteinii has also been implicated in modulating host responses to gastric pathogens. In a study investigating Helicobacter pylori–induced pathogenesis, the commensal strain P. goldsteinii MTS01 was shown to alter gut microbiota composition and significantly reduce host cholesterol levels. These changes were associated with mitigation of H. pylori–associated inflammation and tissue damage. The study suggests that cholesterol metabolism and microbiota remodeling may represent additional mechanisms through which P. goldsteinii exerts protective effects against pathogen-induced gastrointestinal disorders, extending its functional relevance beyond colonic inflammation to broader host–microbe interactions. [6]

3. Gut–Lung Axis and Respiratory Disease Models

P. goldsteinii has also been studied in the context of the gut–lung axis. In a cigarette smoke–induced chronic obstructive pulmonary disease (COPD) mouse model, administration of P. goldsteinii was reported to alleviate lung inflammation and metabolic dysfunction. The same study identified a lipopolysaccharide derived from P. goldsteinii that exhibited anti-inflammatory properties through modulation of Toll-like receptor 4 (TLR4) signaling. [13]

4. Gut–Brain Axis and Parkinson Disease Model

A recent report indicated P. goldsteinii colonization attenuates the progression of LRRK2-associated parkinsonism by restoring intestinal homeostasis and reducing neuroinflammation. These findings underscore the therapeutic potential of modulating the gut-immune-brain axis during the prodromal stage of Parkinson Disease. [10]

5. Extracellular Vesicles and Microbial Communication

P. goldsteinii produces extracellular vesicles(EVs), also referred to as outer membrane vesicles (OMVs). A 2023 study characterized DNA associated with purified extracellular vesicles from P. goldsteinii, suggesting non-random packaging of genetic material at the operon level. [14]

These nanoscale vesicles contain bioactive components such as proteins, lipids, nucleic acids and glycolipids, and are believed to play importrant roles in intercellular communication between microbes and host cells.

Microbial EVs derived from NGPs are an emerging area of research, particularly in understanding how microbial signals influence host immune and metabolic responses. Recent studies have further demonstrated that OMVs derived from P. goldsteinii can modulate inflammatory responses beyond the gastrointestinal tract. In particular, P. goldsteinii-derived OMVs have been shown to suppress skin inflammation in experimental models of psoriasis by regulating immune signaling pathways involved in inflammatory responses.

These findings suggest that microbial EVs functioning as a postbiotic may contribute to the maintenance of skin homeostasis and may play a role in alleviating disease-associated skin conditions, such as psoriasis and atopic dermatitis, through immunomodulatory and anti-inflammatory mechanisms. [15]

Potential Applications and Research Interests

Due to its presence in healthy gut microbiota and its observed biological activities in many experimental models, P. goldsteinii has become a subject of interest in next-generation probiotic (NGP) research and postbiotic science. Research focuses on understanding its safety profile, main functional components, the underlying mechanisms of action (MOA), and potential translational applications.

Safety and Regulatory Status

Although P. goldsteinii was previously reported to be isolated from the human microbiota [16] [17] [18] , however, so far there is no evidence indicating that P. goldsteinii is the causal factor initiating human diseases. To facilitate its use as a commercial food ingredient, a specific strain, P. goldsteinii RV-01, has undergone extensive safety evaluations, including animal toxicity studies. In addition to the three genotoxicity assays, 28-day subacute and 90-day subchronic animal toxicity studies were also implemented. The results of all studies were negative for toxicity. These results support the conclusion that autoclaved P. goldsteinii RV-01 is safe for use as a food ingredient. [19] . Based on these assessments, a panel of qualified experts concluded that the autoclaved (heat-killed) form of this bacterium is safe for its intended use, granting it self-affirmed GRAS status. [20]

References

  1. Parte, A.C. "Parabacteroides". LPSN .
  2. 1 2 3 Wu, Tsung-Ru; Lin, Chuan-Sheng; Chang, Chih-Jung; Lin, Tzu-Lung; Martel, Jan; Ko, Yun-Fei; Ojcius, David M; Lu, Chia-Chen; Young, John D; Lai, Hsin-Chih (February 2019). "Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis". Gut. 68 (2): 248–262. doi:10.1136/gutjnl-2017-315458. ISSN   0017-5749. PMID   30007918.
  3. 1 2 3 Zhao, Feng; Zou, Zhen; Liu, Zhaoyi; Wang, Jiao; Wu, Yuehua; Zhang, Jun; Liu, Qin; Liang, Weijuan; Yao, Jinwen; Jiang, Xuejun; Routledge, Michael N.; Khan, Ahmad; Zhang, Hongyang; Qiu, Jingfu; Chen, Chengzhi (2025-11-12). "A lysine-restricted diet ameliorates obesity via enrichment of Parabacteroides goldsteinii and 1,4-methylimidazoleacetic acid". Nature Communications. 16 (1) 9953. Bibcode:2025NatCo..16.9953Z. doi:10.1038/s41467-025-64892-z. ISSN   2041-1723. PMC   12612160 . PMID   41224764.
  4. 1 2 3 He, Ningning; Mu, Mengjie; Li, Xiaofang; Hao, Qingyuan; Chen, Kaiwei; Zhao, Xinnan; Sun, Yang; Wang, Haoyu; Wu, Zhinan; Liang, Hewei; Wang, Mengmeng; Xiao, Liang; Yu, Tao; Wang, Zhi-Peng; Peng, Jixing (January 2025). "Gut Commensal Antibiotic-Resistant Parabacteroides goldsteinii Ameliorates Mouse Colitis through Valine–Isobutyrate Metabolism". Research. 8 0867. Bibcode:2025Resea...8..867H. doi:10.34133/research.0867. ISSN   2639-5274. PMC   12423503 . PMID   40948937.
  5. 1 2 3 Deng, Xu; Guo, Taozong; He, Yang; Gao, Shengnan; Su, Jirong; Pan, Hongbin; Li, Anjian (2025-04-27). "Parabacteroides goldsteinii Alleviates Intestinal Inflammation in Dextran Sulfate Sodium-Treated Pigs". Animals. 15 (9): 1231. doi: 10.3390/ani15091231 . ISSN   2076-2615. PMC   12071024 . PMID   40362046.
  6. 1 2 3 Lai, Chih-Ho; Lin, Tzu-Lung; Huang, Mei-Zi; Li, Shiao-Wen; Wu, Hui-Yu; Chiu, Ya-Fang; Yang, Chia-Yu; Chiu, Cheng-Hsun; Lai, Hsin-Chih (2022-06-30). "Gut Commensal Parabacteroides goldsteinii MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate Helicobacter pylori-Induced Pathogenesis". Frontiers in Immunology. 13 916848. doi: 10.3389/fimmu.2022.916848 . ISSN   1664-3224.
  7. 1 2 Zhu, Xue-Xue; Fu, Xiao; Meng, Xin-Yu; Su, Jia-Bao; Zheng, Guan-Li; Xu, An-Jing; Chen, Guo; Zhang, Yuan; Liu, Yao; Hou, Xiao-Hui; Qiu, Hong-Bo; Sun, Qing-Yi; Hu, Jin-Yi; Lv, Zhuo-Lin; Wang, Yao (November 2024). "Gut microbiome and metabolites mediate the benefits of caloric restriction in mice after acute kidney injury". Redox Biology. 77 103373. doi:10.1016/j.redox.2024.103373. ISSN   2213-2317.
  8. 1 2 Gu, Peng; Wei, Rongjuan; Liu, Ruofan; Yang, Qin; He, Yuxuan; Guan, Jianbin; He, Wenhao; Li, Jiaxin; Zhao, Yunfei; Xie, Li; He, Jie; Guo, Qingling; Hu, Jiajia; Bao, Jingna; Wang, Wandang (March 2025). "Aging-induced Alternation in the Gut Microbiota Impairs Host Antibacterial Defense". Advanced Science. 12 (12) 2411008. Bibcode:2025AdvSc..1211008G. doi:10.1002/advs.202411008. ISSN   2198-3844. PMID   39792643.
  9. 1 2 3 Li, Ziyun; Zhang, Li; Wan, Zhenxia; Liu, Huijuan; Zhang, Ting; Li, Yan (2025-09-11). "Therapeutic potential of the gut commensal bacterium Parabacteroides goldsteinii in human health and disease treatment". Frontiers in Microbiology. 16 1618892. doi: 10.3389/fmicb.2025.1618892 . ISSN   1664-302X. PMC   12461743 . PMID   41019532.
  10. 1 2 3 Lin, Jian-Da; Li, Hsun; Hsu, Chia-Lang; Lin, Tzu-Lung; Chuang, Hsiao-Li; Lin, Han-I; Ho, En-Peng; Chen, Yi-Hsuan; Liu, Chia-Wei; Chuang, Ya-Ting; Lung, Yun-Yi; Lien, Chia-Jung; Chen, Huan-Yun; Wu, Wei-Kai; Wu, Ming-Shiang (December 2025). "Parabacteroides goldsteinii mitigates parkinsonism in LRRK2 mutant mice by reducing neuroinflammation through Gut-Brain axis". Journal of Advanced Research. doi:10.1016/j.jare.2025.12.028. PMID   41448457.
  11. 1 2 Liu, Jing; Qiu, Hui; Zhao, Jiamin; Shao, Nan; Chen, Chao; He, Zhixu; Zhao, Xu; Zhao, Juanjuan; Zhou, Ya; Xu, Lin (2025-07-19). "Parabacteroides as a promising target for disease intervention: current stage and pending issues". npj Biofilms and Microbiomes. 11 (1) 137. doi:10.1038/s41522-025-00772-0. ISSN   2055-5008. PMID   40681519.
  12. Shah, Haroun N.; Olsen, Ingar; Bernard, Kathy; Finegold, Sydney M.; Gharbia, Saheer; Gupta, Radhey S. (October 2009). "Approaches to the study of the systematics of anaerobic, Gram-negative, non-sporeforming rods: Current status and perspectives". Anaerobe. 15 (5): 179–194. doi:10.1016/j.anaerobe.2009.08.003. PMID   19695337.
  13. Lai, Hsin-Chih; Lin, Tzu-Lung; Chen, Ting-Wen; Kuo, Yu-Lun; Chang, Chih-Jung; Wu, Tsung-Ru; Shu, Ching-Chung; Tsai, Ying-Huang; Swift, Simon; Lu, Chia-Chen (2021-03-09). "Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide". Gut. 71 (2): 309–321. doi:10.1136/gutjnl-2020-322599. ISSN   0017-5749. PMID   33687943.
  14. Cho, Byeongyeon; Moore, Grace; Pham, Loc-Duyen; Patel, Chirag; Kostic, Aleksandar (2023-12-04). "DNA characterization reveals potential operon-unit packaging of extracellular vesicle cargo from a gut bacterial symbiont". doi.org. doi:10.21203/rs.3.rs-3689023/v1.
  15. Su, Dandan; Li, Manchun; Xie, Yuedong; Xu, Zhanxue; Lv, Guowen; Jiu, Yaming; Lin, Jingxiong; Chang, Chih-Jung; Chen, Hongbo; Cheng, Fang (January 2025). "Gut commensal bacteria Parabacteroides goldsteinii-derived outer membrane vesicles suppress skin inflammation in psoriasis". Journal of Controlled Release. 377: 127–145. doi:10.1016/j.jconrel.2024.11.014. ISSN   0168-3659. PMID   39532207.
  16. Song, Yuli; Liu, Chengxu; Lee, Julia; Bolaňos, Mauricio; Vaisanen, Marja-Liisa; Finegold, Sydney M. (September 2005). ""Bacteroides goldsteiniisp. nov." Isolated from Clinical Specimens of Human Intestinal Origin". Journal of Clinical Microbiology. 43 (9): 4522–4527. doi:10.1128/jcm.43.9.4522-4527.2005. ISSN   0095-1137. PMC   1234108 . PMID   16145101.
  17. Sakamoto, M.; Suzuki, N.; Matsunaga, N.; Koshihara, K.; Seki, M.; Komiya, H.; Benno, Y. (2009-07-23). "Parabacteroides gordonii sp. nov., isolated from human blood cultures". International Journal of Systematic and Evolutionary Microbiology. 59 (11): 2843–2847. doi:10.1099/ijs.0.010611-0. ISSN   1466-5026.
  18. Awadel-Kariem, F. Mustafa; Patel, P.; Kapoor, J.; Brazier, Jon S.; Goldstein, Ellie J.C. (June 2010). "First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection". Anaerobe. 16 (3): 223–225. doi:10.1016/j.anaerobe.2010.01.001. ISSN   1075-9964.
  19. Lin, Tzu-Lung; Chen, Wan-Jiun; Hung, Chien-Min; Wong, Yea-Lin; Lu, Chia-Chen; Lai, Hsin-Chih (2024-11-25). "Characterization and Safety Evaluation of Autoclaved Gut Commensal Parabacteroides goldsteinii RV-01". International Journal of Molecular Sciences. 25 (23) 12660. doi: 10.3390/ijms252312660 . ISSN   1422-0067.
  20. "GRAS Notices". hfpappexternal.fda.gov. Retrieved 2026-01-28.